These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5156957)

  • 1. The adrenergic modulation of the serum insulin response to intravenous arginine in man.
    London DR; Bacchus RA; Bold AM; Meade L; Sacre M; Taberner M; Walker G
    Eur J Clin Invest; 1971 Nov; 2(1):52-8. PubMed ID: 5156957
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the regulation of insulin and growth hormone secretion in the sheep.
    Hertelendy F; Machlin L; Kipnis DM
    Endocrinology; 1969 Feb; 84(2):92-9. PubMed ID: 5764317
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of adrenergic receptor stimulation on glucose metabolism during starvation in man: effects on circulating levels of insulin growth hormone and free fatty acids.
    Misbin RI; Edgar PJ; Lockwood DH
    Metabolism; 1971 Jun; 20(6):544-54. PubMed ID: 4325409
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of adrenaline on plasma levels of fatty acid in adrenalectomized rats. Possible role of adrenergic receptors].
    Baïsset A; Berlan M; Montastruc P
    C R Acad Hebd Seances Acad Sci D; 1975 Jan; 280(1):97-100. PubMed ID: 806381
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenergic regulation of basal serum glucose, NEFA and insulin levels.
    Gagliardino JJ; Bellone CF; Doria I; Sănchez JJ; Pereyra V
    Horm Metab Res; 1970 Nov; 2(6):318-22. PubMed ID: 4398896
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic modulation of basal insulin secretion in man.
    Robertson RP; Porte D
    Diabetes; 1973 Jan; 22(1):1-8. PubMed ID: 4683792
    [No Abstract]   [Full Text] [Related]  

  • 9. Human maternal and fetal insulin response to arginine.
    King KC; Butt J; Raivio K; Räihä N; Roux J; Teramo K; Yamaguchi K; Schwartz R
    N Engl J Med; 1971 Sep; 285(11):607-12. PubMed ID: 5563962
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
    Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR
    J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA; Vinik AI; Levitt N
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
    Knudtzon J
    J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic effects which modify arginine-induced insulin release in man.
    Floyd JC; Fajans SS; Pek S; Knopf RF; Weissman P; Conn JW
    J Lab Clin Med; 1971 Dec; 78(6):990-1. PubMed ID: 5131871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients].
    Cucinotta D; Quartarone M; Di Cesare E; Longo G; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2283-9. PubMed ID: 754728
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal variation in glucose tolerance and in insulin secretion in man.
    Carroll KF; Nestel PJ
    Diabetes; 1973 May; 22(5):333-48. PubMed ID: 4700047
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine-induced insulin and substrate changes in normal man: incomplete reversal by phentolamine.
    Meguid MM; Moore Ede MC; Fitzpatrick G; Moore FD
    J Surg Res; 1975 Apr; 18(4):365-9. PubMed ID: 1142752
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of adrenaline on insulin-induced release of growth hormone and cortisol in man.
    Müller-Hess R; Geser CA; Jéquier E; Felber JP; Vannotti A
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):260-73. PubMed ID: 4406545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.